查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1497654

3D 生物列印市场：按组件、技术和最终用户划分 - 2024-2030 年全球预测

3D Bioprinting Market by Component (3D Bioprinters, Bioinks), Technology (Extrusion-based Bioprinting, Inkjet-based Bioprinting, Laser-assisted Bioprinting), End-user - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年3D生物列印市场规模为17.9亿美元，预计2024年将达21.4亿美元，2030年将达到63.9亿美元，复合年增长率为19.89%。

3D 生物列印是一种将生物墨水与活细胞融合以创建类似组织的 3D 结构的技术。该过程在3D空间中逐层列印生物墨水和细胞的混合物。近年来，对3D生物列印技术的需求显着增长，并已成为各种生物医学应用的重要工具。疾病建模和组织工程是这项创新技术产生重大影响的两个重要领域。全球慢性病数量迅速增加，以及对有效治疗的需求不断增长，正在推动对 3D 生物列印彻底改变医疗保健潜力的研究。此外，对个人化医疗应用的需求不断增长，需要根据个人需求量身定製配方和治疗方法，而 3D 生物列印在实现基于患者遗传特征和疾病特征的客製化方面发挥关键作用。可扩展性是 3D 生物列印的关键问题。创造更大、更复杂的组织和器官需要提高列印过程的速度和精确度。然而，近年来，专注于开髮用于 3D 生物列印应用的新型生医材料的研究显着增加。由天然和合成聚合物组成的新型生物墨水专为 3D 生物列印而设计。与传统材料相比，这些生医材料具有多种优势，包括提高的生物相容性、可调节的机械性能和改善的细胞黏附性能，这些性能对于组织再生至关重要。

主要市场统计
基准年[2023] 17.9亿美元
预测年份 [2024] 21.4亿美元
预测年份 [2030] 63.9亿美元
复合年增长率（%） 19.89%

区域洞察

由于技术进步、成熟的製药业和强大的研究基础设施，美洲 3D 生物列印市场正在不断成长。美国在美国地区占有重要地位，拥有大量联邦资金支持3D生物列印研发计划。此外，北美的一些学术机构还建立了专用3D生物列印的研究设施。欧洲正在经历慢性病的增加和人口老化，迫切需要更有效的药物和个人化治疗，并推动 3D 生物列印等生物技术的进步。在欧洲，德国、英国、法国和瑞典等国家已成为製药领域采用3D生物列印技术的重要参与者。近年来，亚洲已成为器官移植的中心，随着该地区人口的增长、预期寿命的延长以及慢性病和需要器官移植的疾病的数量相应增加，3D生物列印技术的进步正在迅速加速。此外，亚洲国家之间在医学研究和技术方面区域合作的发展也对这一增长做出了重大贡献。印度和中国在开发新颖解决方案方面拥有强大的立足点，并专注于 3D 生物列印技术，例如使用积层製造製程的生物人工器官。

FPNV定位矩阵

FPNV定位矩阵对于评估供应商在3D生物列印市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可对 3D 生物列印市场中供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外，该分析还提供了对该行业竞争力的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在 3D 生物列印市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对疾病模型和组织工程的需求不断增长
      • 药物和锭剂研究中越来越多地采用 3D 生物列印
    • 抑制因素
      • 对合适印刷材料的扩充性和可用性的担忧
    • 机会
      • 增加为博士学术计划提供的研究经费
      • 3D 生物列印机和生医材料的爆炸性进步
    • 任务
      • 细胞生物学研究需要大量资金
  • 市场区隔分析
    • 组成部分：扩大可适应各种应用的 3D 生物列印机的使用
    • 最终用户：製药和生物技术公司的 3D 生物列印使用量激增
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第 6 章 3D 生物列印市场：按组成部分

  • 3D生物列印机
  • 生物墨水

第 7 章 3D 生物列印市场：依技术分类

  • 挤压法生物列印
  • 基于喷墨的生物列印
  • 雷射辅助生物列印

第 8 章 3D 生物列印市场：依最终用户划分

  • 製药和生物技术公司
  • 调查机构

第9章美洲3D生物列印市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太3D生物列印市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的3D生物列印市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Readyly3D推出先进的生物墨水，可精确列印复杂组织
    • BIO INX 与 Rousselot 合作推进 3D 生物列印材料
    • Nexa3D 透过收购 Essentium 扩大市场规模
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-43649B5EE3C4

[189 Pages Report] The 3D Bioprinting Market size was estimated at USD 1.79 billion in 2023 and expected to reach USD 2.14 billion in 2024, at a CAGR 19.89% to reach USD 6.39 billion by 2030.

3D bioprinting is technology that merges bioinks and living cells to fabricate 3D structures resembling tissues. This process entails printing the bioink and cell mixture layer by layer in a three-dimensional space. In recent years, the demand for 3D bioprinting technologies has experienced significant growth, emerging as a vital tool in various biomedical applications. Disease modeling and tissue engineering are two critical areas in which this innovative technology is making a substantial impact. The burgeoning prevalence of chronic diseases globally and an increasing need for effective treatments have spurred researchers to explore the potential of 3D bioprinting in revolutionizing healthcare. Additionally, there has been a rising demand for personalized medicine applications that necessitate patient-specific drug formulations and treatments tailored to individual needs, where 3D bioprinting plays an essential role by allowing for customization based on patients' genetic profiles or disease characteristics. Scalability remains a significant challenge for 3D bioprinting as current technologies primarily focus on producing smaller tissue constructs. Creating larger and more complex tissues and organs requires advancements in both the speed and precision of printing processes. However, there has been a marked increase in research focused on developing novel biomaterials for 3D bioprinting applications in recent years. New bioinks composed of natural and synthetic polymers are explicitly designed for 3D bioprinting. These biomaterials offer several advantages over conventional materials, including enhanced biocompatibility, tunable mechanical properties, and improved cell adhesion characteristics, essentially required for tissue regeneration.

KEY MARKET STATISTICS
Base Year [2023] USD 1.79 billion
Estimated Year [2024] USD 2.14 billion
Forecast Year [2030] USD 6.39 billion
CAGR (%) 19.89%

Regional Insights

The Americas 3D bioprinting market is growing due to technological advancement, a well-established pharmaceutical industry, and a robust research infrastructure. The United States witnessed a significant position in the American region with notable federal funding to support R&D projects in 3D bioprinting. Furthermore, several North American academic institutions have established dedicated 3D bioprinting research facilities. Europe has been witnessing an increasing prevalence of chronic diseases and an expanding geriatric population, creating an urgent need for more effective pharmaceutical drugs and personalized treatments, which has boosted the advancements in biotechnology, such as 3D bioprinting. Across Europe, countries such as Germany, the UK, France, and Sweden have emerged as critical players in adopting 3D bioprinting technologies within their pharmaceutical sectors. In recent years, Asia has emerged as a rising hub for organ transplantation, and 3D bioprinting advancements surged majorly due to the region's growing population, its increasing life expectancy, and the subsequent rise in chronic diseases and ailments requiring organ transplants. Furthermore, the development of regional collaboration among Asian countries in medical research and technology has significantly contributed to this growth. India and China have established a strong foothold in developing novel solutions and have specialized in 3D bioprinting technologies such as bioartificial organs using additive manufacturing processes.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the 3D Bioprinting Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising demand for disease modeling and tissue engineering
      • Increase in deployment of 3D bioprinting across research of drugs and pills
    • Market Restraints
      • Concern over scalability and availability of suitable printing materials
    • Market Opportunities
      • Increasing research funding provided to doctoral academic projects
      • Proliferation in advancements of 3D bioprinters and biomaterials
    • Market Challenges
      • Capital intensive to perform cell biology research
  • Market Segmentation Analysis
    • Component: Proliferating utilization of the 3D bioprinters capable of adapting to a range of applications
    • End-user: Burgeoning usage of the 3D bioprinting across the pharmaceutical & biotechnology companies
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the 3D Bioprinting Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the 3D Bioprinting Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Readily3D Unveils Advanced Bio-Inks for Precision 3D Bioprinting of Complex Tissues

Readily3D, a Swiss company specializing in 3D printing technologies, has announced the development of next-generation bio-inks for use in medical applications. This innovative product aims to enhance organ and tissue modeling by addressing the demand for high precision and compatibility in 3D bioprinting. By optimizing the viscosity of these bio-inks, Readily3D ensures smoother functioning in printing mechanisms, which is crucial for creating complex tissues such as those found in the human pancreas. This advancement promises to drive forward the capabilities in medical research and transplantation. It aligns with broader efforts in the industry to tailor bioprinting materials for specific medical needs, potentially revolutionizing patient-specific treatments. [Published On: 2024-05-23]

BIO INX Partners with Rousselot for Advancements in 3D Bioprinting Materials

BIO INX has partnered with Rousselot, a player in gelatin production, to elevate the field of 3D bioprinting. This partnership aims to leverage Rousselot's extensive expertise in gelatin formulation to revolutionize the development of high-quality bio inks. Such innovative bioinks are crucial for advancing 3D bioprinting technologies, which are pivotal in generating complex biological structures that can potentially lead to medical research and treatment breakthroughs. This partnership is set to combine BIO INX's cutting-edge bioprinting techniques with Rousselot's long-standing excellence in gelatin expertise, setting a promising path toward significant enhancements in the quality and performance of 3D printed products. [Published On: 2024-03-12]

Nexa3D Expands Market Footprint with the Acquisition of Essentium

Nexa3D, a player in ultra-fast stereolithography 3D printers, announced the acquisition of Essentium to broaden its capabilities and market reach in the high-speed extrusion (HSE) 3D printing sector. This transaction marks a significant step for Nexa3D in expanding its high-speed polymer 3D printers and materials portfolio. Essentium is renowned for its groundbreaking HSE 3D printing platform, which complements Nexa3D's existing product offerings and is expected to enhance its operational scale and innovation capacity in serving a growing global customer base. This acquisition aligns with Nexa3D's strategy to lead the additive manufacturing industry by integrating and optimizing production workflows and democratizing access to scalable additive manufacturing solutions. [Published On: 2024-01-12]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the 3D Bioprinting Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the 3D Bioprinting Market, highlighting leading vendors and their innovative profiles. These include 3D BioFibR, 3D Bioprinting Solutions, 3D Systems Corporation, Advanced Solutions, Inc., Aspect Biosystems Ltd., Avay Biosciences Private Limited, Axiom Space, Inc., Axolotl Biosystems Ltd., BICO Group AB, Brinter Inc., Cellbricks GmbH, CollPlant Biotechnologies Ltd., Cyfuse Biomedical K.K., Desktop Metal, Inc., Fluicell AB, FluidForm, Inc., FUJIFILM Corporation, GE HealthCare Technologies Inc., GeSiM, Inventia Life Science Pty Ltd., Medprin Regenerative Medical Technologies Co., Ltd., Merck KGaA, Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., Precise Bio Inc., Prellis Biologics, PrintBio, Inc, REGEMAT 3D S.L., regenHU Ltd., Regenovo Biotechnology Co., Ltd. by Shining 3D Tech Co., Ltd., ROKIT Healthcare Inc., TheWell Bioscience Inc., UPM-Kymmene Corporation, and UpNano GmbH.

Market Segmentation & Coverage

This research report categorizes the 3D Bioprinting Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • 3D Bioprinters
    • Bioinks
  • Technology
    • Extrusion-based Bioprinting
    • Inkjet-based Bioprinting
    • Laser-assisted Bioprinting
  • End-user
    • Pharmaceutical & Biotechnology Companies
    • Research Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for disease modeling and tissue engineering
      • 5.1.1.2. Increase in deployment of 3D bioprinting across research of drugs and pills
    • 5.1.2. Restraints
      • 5.1.2.1. Concern over scalability and availability of suitable printing materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing research funding provided to doctoral academic projects
      • 5.1.3.2. Proliferation in advancements of 3D bioprinters and biomaterials
    • 5.1.4. Challenges
      • 5.1.4.1. Capital intensive to perform cell biology research
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Proliferating utilization of the 3D bioprinters capable of adapting to a range of applications
    • 5.2.2. End-user: Burgeoning usage of the 3D bioprinting across the pharmaceutical & biotechnology companies
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. 3D Bioprinting Market, by Component

  • 6.1. Introduction
  • 6.2. 3D Bioprinters
  • 6.3. Bioinks

7. 3D Bioprinting Market, by Technology

  • 7.1. Introduction
  • 7.2. Extrusion-based Bioprinting
  • 7.3. Inkjet-based Bioprinting
  • 7.4. Laser-assisted Bioprinting

8. 3D Bioprinting Market, by End-user

  • 8.1. Introduction
  • 8.2. Pharmaceutical & Biotechnology Companies
  • 8.3. Research Organizations

9. Americas 3D Bioprinting Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific 3D Bioprinting Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa 3D Bioprinting Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Readily3D Unveils Advanced Bio-Inks for Precision 3D Bioprinting of Complex Tissues
    • 12.3.2. BIO INX Partners with Rousselot for Advancements in 3D Bioprinting Materials
    • 12.3.3. Nexa3D Expands Market Footprint with the Acquisition of Essentium
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. 3D BIOPRINTING MARKET RESEARCH PROCESS
  • FIGURE 2. 3D BIOPRINTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL 3D BIOPRINTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL 3D BIOPRINTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL 3D BIOPRINTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. 3D BIOPRINTING MARKET DYNAMICS
  • FIGURE 7. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. 3D BIOPRINTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. 3D BIOPRINTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. 3D BIOPRINTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL 3D BIOPRINTING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL 3D BIOPRINTING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL 3D BIOPRINTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL 3D BIOPRINTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL 3D BIOPRINTING MARKET SIZE, BY 3D BIOPRINTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL 3D BIOPRINTING MARKET SIZE, BY 3D BIOPRINTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL 3D BIOPRINTING MARKET SIZE, BY BIOINKS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL 3D BIOPRINTING MARKET SIZE, BY BIOINKS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL 3D BIOPRINTING MARKET SIZE, BY EXTRUSION-BASED BIOPRINTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL 3D BIOPRINTING MARKET SIZE, BY EXTRUSION-BASED BIOPRINTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL 3D BIOPRINTING MARKET SIZE, BY INKJET-BASED BIOPRINTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL 3D BIOPRINTING MARKET SIZE, BY INKJET-BASED BIOPRINTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL 3D BIOPRINTING MARKET SIZE, BY LASER-ASSISTED BIOPRINTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL 3D BIOPRINTING MARKET SIZE, BY LASER-ASSISTED BIOPRINTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL 3D BIOPRINTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL 3D BIOPRINTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL 3D BIOPRINTING MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL 3D BIOPRINTING MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 28. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 35. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 36. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 37. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 38. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 41. BRAZIL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 42. BRAZIL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 47. CANADA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 48. CANADA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 51. CANADA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 52. CANADA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 53. MEXICO 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 54. MEXICO 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 55. MEXICO 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 56. MEXICO 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 57. MEXICO 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 58. MEXICO 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 59. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 60. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 61. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 62. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 76. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 78. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 80. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 81. CHINA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 82. CHINA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 83. CHINA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 84. CHINA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 85. CHINA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. CHINA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. INDIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 88. INDIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 89. INDIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 90. INDIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 91. INDIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. INDIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. INDONESIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 94. INDONESIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 95. INDONESIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 96. INDONESIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 97. INDONESIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 98. INDONESIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 99. JAPAN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 100. JAPAN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 101. JAPAN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 102. JAPAN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 103. JAPAN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 104. JAPAN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 105. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 106. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 107. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 108. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 109. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 110. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 112. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 114. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 116. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 117. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 118. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 119. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 120. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 121. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 122. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 124. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 126. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 128. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 129. TAIWAN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 130. TAIWAN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 131. TAIWAN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 132. TAIWAN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 133. TAIWAN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. TAIWAN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. THAILAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 136. THAILAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 137. THAILAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 138. THAILAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 139. THAILAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. THAILAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. VIETNAM 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 142. VIETNAM 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 143. VIETNAM 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 144. VIETNAM 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 145. VIETNAM 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 146. VIETNAM 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 155. DENMARK 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 156. DENMARK 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 157. DENMARK 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 158. DENMARK 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 159. DENMARK 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. DENMARK 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. EGYPT 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 162. EGYPT 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 163. EGYPT 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 164. EGYPT 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 165. EGYPT 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. EGYPT 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. FINLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 168. FINLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 169. FINLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 170. FINLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 171. FINLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 172. FINLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 173. FRANCE 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 174. FRANCE 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 175. FRANCE 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 176. FRANCE 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 177. FRANCE 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 178. FRANCE 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 179. GERMANY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 180. GERMANY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 181. GERMANY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 182. GERMANY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 183. GERMANY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 184. GERMANY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 185. ISRAEL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 186. ISRAEL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 187. ISRAEL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 188. ISRAEL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 189. ISRAEL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. ISRAEL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. ITALY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 192. ITALY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 193. ITALY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 194. ITALY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 195. ITALY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 196. ITALY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 198. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 200. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 202. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 203. NIGERIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 204. NIGERIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 205. NIGERIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 206. NIGERIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 207. NIGERIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 208. NIGERIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 209. NORWAY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 210. NORWAY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 211. NORWAY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 212. NORWAY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 213. NORWAY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 214. NORWAY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 215. POLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 216. POLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 217. POLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 218. POLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 219. POLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. POLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. QATAR 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 222. QATAR 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 223. QATAR 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 224. QATAR 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 225. QATAR 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 226. QATAR 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 227. RUSSIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 228. RUSSIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 229. RUSSIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 230. RUSSIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 231. RUSSIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 232. RUSSIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 234. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 236. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 238. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 245. SPAIN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 246. SPAIN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 247. SPAIN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 248. SPAIN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 249. SPAIN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. SPAIN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. SWEDEN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 252. SWEDEN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 253. SWEDEN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 254. SWEDEN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 255. SWEDEN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. SWEDEN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 258. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 260. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 262. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 263. TURKEY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 264. TURKEY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 265. TURKEY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 266. TURKEY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 267. TURKEY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. TURKEY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 281. 3D BIOPRINTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 282. 3D BIOPRINTING MARKET, FPNV POSITIONING MATRIX, 2023